Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Bay City Capital GF Xinde International Life Sciences Fund

Bay City Capital GF Xinde is a cross-border life sciences venture capital fund with a global diversified strategy ranging from seed stage to public companies, and including innovation, restructuring opportunities, and growth investing. To learn more, visit www.baycitycapital.com or www.gf.com.cn. *

 

Period Start 2018-01-04 existent
  Group Bay City Capital LLC
Products Industry venture capital
  Industry 2 LIFE SCIENCES
     
Region Region San Francisco, CA
  Country United States (USA)
  City n. a. 
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Oculis S.A.. (1/4/18). "Press Release: Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases". Lausanne.
     
   
Record changed: 2021-05-24

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Bay City Capital LLC


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top